HCG Enterprises has unveiled the first Tomotherapy H Series with HDA configuration machine for treating cancer.
Developed by Accuray, this Tomotherapy H Series with HDA configuration features the TomoHDA System, which helps in accurate treatment of cancerous cells through targeted dosages, can aid in better planning, faster delivery and better quality of the treatment, according to company executives.
It works on the principle of Intensity modulated Radiotherapy (IMRT) the core of Radiotherapy, the machine comes with a 3D image-guided, full spectrum radiation therapy system, offers multiple new benefits including performance enhancements, unrivalled dose distributions and faster treatments, according to company executives.
B.S Ajaikumar, Chairman, HCG Enterprises, also a leading doctor with more than three decades of experience in the field of oncology said, “Tomotherapy’s ability to treat a full range of disease sites, including even the most complex tumours, makes it an invaluable resource for cancer patients.”
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.